All Stories

  1. Is Shifting to a Progestin Worthwhile When Estrogen–Progestins Are Inefficacious for Endometriosis-Associated Pain?
  2. The oncofetal protein IMP3: a novel biomarker and triage tool for premalignant atypical endometriotic lesions
  3. RETRACTED: Attractiveness of women with rectovaginal endometriosis: a case-control study